Issue
Alert me when new journal issues are available via or via
Introduction
Introduction Alan L Robin pages S117-S118 Full Text | Full-Text PDF (93 KB)
Articles
Preclinical Overview of Brinzolamide Louis DeSantis pages S119-S129 Abstract | Full Text | Full-Text PDF (186 KB)
Increased Optic Nerve Head Blood Flow After 1 Week of Twice Daily Topical Brinzolamide Treatment in Dutch-Belted Rabbits George E Barnes, Byron Li, Tom Dean, Michael L Chandler pages S131-S140 Abstract | Full Text | Full-Text PDF (244 KB)
Ocular Comfort of Brinzolamide 1.0% Ophthalmic Suspension Compared With Dorzolamide 2.0% Ophthalmic Solution: Results From Two Multicenter Comfort Studies Lewis H Silver, the Brinzolamide Comfort Study Group pages S141-S145 Abstract | Full Text | Full-Text PDF (143 KB)
Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt®) Lewis H. Silver, the Brinzolamide Dose-Response Study Group pages S147-S153 Abstract | Full Text | Full-Text PDF (130 KB)
The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension Kenneth Sall, the Brinzolamide Primary Therapy Study Group pages S155-S162 Abstract | Full Text | Full-Text PDF (120 KB)
Adjunctive Therapy With Brinzolamide 1% Ophthalmic Suspension (Azopt®) in Patients With Open-Angle Glaucoma or Ocular Hypertension Maintained on Timolol Therapy Dong Shin, the Brinzolamide Adjunctive Therapy Study Group pages S163-S168 Abstract | Full Text | Full-Text PDF (124 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
